Advertisement

Heart and Vessels

, Volume 32, Issue 11, pp 1314–1319 | Cite as

Periodontitis deteriorates peripheral arterial disease in Japanese population via enhanced systemic inflammation

  • Norio Aoyama
  • Jun-ichi Suzuki
  • Naho Kobayashi
  • Tomoya Hanatani
  • Norihiko Ashigaki
  • Asuka Yoshida
  • Yuka Shiheido
  • Hiroki Sato
  • Hidetoshi Kumagai
  • Yuichi Ikeda
  • Hiroshi Akazawa
  • Issei Komuro
  • Yuichi Izumi
  • Mitsuaki Isobe
Original Article

Abstract

Peripheral arterial disease (PAD) is a common manifestation of arterial stenosis of the extremity that reduces arterial flow. While patients with periodontitis are at a high risk of PAD, little causal information has been provided to date. To clarify the relationship, we conducted this cross-sectional study. The oral condition of patients with or without PAD, who attended Tokyo Medical and Dental University Hospital, was evaluated. Blood examinations and dental clinical measurements, including number of teeth, probing pocket depth (PPD), bleeding on probing (BOP) and clinical attachment level (CAL) were performed. Chi-square test was performed to compare gender, smoker rate, prevalence of DM, hypertension and dyslipidemia and edentulous rate. Wilcoxon test was used to compare bacterial counts and anti-bacterial antibodies and Student’s t test was used to compare the other numerical values. The subjects were patients with (n = 34) or without (n = 956) PAD. We revealed that the PAD patients had more missing teeth (17.5 ± 11.0), a higher rate of edentulism (18%), and higher serum inflammatory factor levels than non-PAD patients (10.9 ± 8.7, 5%, respectively). On the other hand, there was no significant difference between hypertension, dyslipidemia, smoking status, HbA1c, bacterial antibody titers, and bacterial counts between the groups. In conclusion, we clarified that PAD patients had decreased tooth number and worsened oral and periodontal condition with enhanced systemic inflammation.

Keywords

Inflammation Periodontal disease Peripheral artery disease 

Notes

Acknowledgements

The authors wish to thank Dr. Makoto Kaneko, Dr. Katsuhiko Matsuo and Dr. Chisato Takamura for excellent assistance. This work was supported by JSPS KAKENHI Grant Numbers (JP25870198, JP15K20616, and JP16H05824), Ministry of Education, Culture, Sports, Science and Technology of Japan, Mitsui Life Insurance Research Foundation, Mitsui Sumitomo Marine Welfare Research Foundation, Geriatric Dental Research Foundation, Human Health Future Research Foundation, St. Luke’s Hospital Research Foundation, Health Management Foundation, Taiyo Life Insurance Research Foundation, The 8020 Promotion Foundation, Terumo Science Foundation, Pfizer Health Research Foundation, General Health Promotion Foundation, Suzuken Memorial Foundation, Health Science Center Foundation, Kobayashi International Scholarship Foundation, Banyu Life Science Foundation International, Japan Heart Foundation & Astellas Grant for Research on Atherosclerosis Update and Hakujikai Institute of Gerontology Foundation.

Compliance with ethical standards

Funding

This work was supported by JSPS KAKENHI Grant Numbers (JP25870198, JP15K20616, and JP16H05824), Ministry of Education, Culture, Sports, Science and Technology of Japan, Mitsui Life Insurance Research Foundation, Mitsui Sumitomo Marine Welfare Research Foundation, Geriatric Dental Research Foundation, Human Health Future Research Foundation, St. Luke’s Hospital Research Foundation, Health Management Foundation, Taiyo Life Insurance Research Foundation, The 8020 Promotion Foundation, Terumo Science Foundation, Pfizer Health Research Foundation, General Health Promotion Foundation, Suzuken Memorial Foundation, Health Science Center Foundation, Kobayashi International Scholarship Foundation, Banyu Life Science Foundation International, Japan Heart Foundation & Astellas Grant for Research on Atherosclerosis Update and Hakujikai Institute of Gerontology Foundation.

Conflict of interest

No other declared.

References

  1. 1.
    Ouma GO, Jonas RA, Usman MH, Mohler ER 3rd (2012) Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease. Vasc Med 17:174–192CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS (1989) Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 9:691–696CrossRefPubMedGoogle Scholar
  3. 3.
    Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, Browner D (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386CrossRefPubMedGoogle Scholar
  4. 4.
    McKenna M, Wolfson S, Kuller L (1991) The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87:119–128CrossRefPubMedGoogle Scholar
  5. 5.
    Klop RB, Eikelboom BC, Taks AC (1991) Screening of the internal carotid arteries in patients with peripheral vascular disease by colour-flow duplex scanning. Eur J Vasc Surg 5:41–45CrossRefPubMedGoogle Scholar
  6. 6.
    Valentine RJ, Grayburn PA, Eichhorn EJ, Myers SI, Clagett GP (1994) Coronary artery disease is highly prevalent among patients with premature peripheral vascular disease. J Vasc Surg 19:668–674CrossRefPubMedGoogle Scholar
  7. 7.
    McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795–2804CrossRefPubMedGoogle Scholar
  8. 8.
    Criqui MH, Denenberg JO, Langer RD, Fronek A (1997) The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 2:221–226CrossRefPubMedGoogle Scholar
  9. 9.
    Stoyioglou A, Jaff MR (2004) Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol 15:1197–1220CrossRefPubMedGoogle Scholar
  10. 10.
    Blaizot A, Vergnes JN, Nuwwareh S, Amar J, Sixou M (2009) Periodontal disease and cardiovascular events: meta-analysis of observational studies. Int Dent J 59:197–209PubMedGoogle Scholar
  11. 11.
    Leira Y, Blanco M, Blanco J, Castillo J (2015) Association between periodontal disease and cerebrovascular disease. A review of the literature. Rev Neurol 61:29–38PubMedGoogle Scholar
  12. 12.
    Soto-Barreras U, Olvera-Rubio JO, Loyola-Rodriquez JP, Reyes-Macias JF, Martinez-Martinez RE, Patiño-Marin N, Martinez-Castañon GA, Aradillas-Garcia C, Little JW (2013) Peripheral arterial disease associated with caries and periodontal disease. J Periodontol 84:486–494CrossRefPubMedGoogle Scholar
  13. 13.
    Chen YW, Umeda M, Nagasawa T, Takeuchi Y, Huang Y, Inoue Y, Iwai T, Izumi Y, Ishikawa I (2008) Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg 35:153–158CrossRefPubMedGoogle Scholar
  14. 14.
    Mendez MV, Scott T, LaMorte W, Vokonas P, Menzoian JO, Garcia R (1998) An association between periodontal disease and peripheral vascular disease. Am J Surg 176:153–157CrossRefPubMedGoogle Scholar
  15. 15.
    Hung HC, Willett W, Merchant A, Rosner BA, Ascherio A, Joshipura KJ (2003) Oral health and peripheral arterial disease. Circulation 107:1152–1157CrossRefPubMedGoogle Scholar
  16. 16.
    Lu B, Parker D, Eaton CB (2008) Relationship of periodontal attachment loss to peripheral vascular disease: an analysis of NHANES 1999–2002 data. Atherosclerosis 200:199–205CrossRefPubMedGoogle Scholar
  17. 17.
    Kofler S, Nickel T, Weis M (2005) Role of cytokines in cardiovascular disease: a focus on endothelial responses to inflammation. Clin Sci (Lond) 108:205–213CrossRefGoogle Scholar
  18. 18.
    Botti C, Maione C, Dogliotti G, Russo P, Signoriello G, Molinari AM, Corsi MM, Sica V, Cobellis G (2012) Circulating cytokines present in the serum of peripheral arterial disease patients induce endothelial dysfunction. J Biol Regul Homeost Agents 26:67–79PubMedGoogle Scholar
  19. 19.
    Moreno VP, Subira D, Meseguer E, Llamas P (2008) IL-6 as a biomarker of ischemic cerebrovascular disease. Biomark Med 2:125–136CrossRefPubMedGoogle Scholar
  20. 20.
    Suzuki J, Imai Y, Aoki M, Fujita D, Aoyama N, Tada Y, Akazawa H, Izumi Y, Isobe M, Komuro I, Nagai R, Hirata Y (2015) High incidence and severity of periodontitis in patients with Marfan syndrome in Japan. Heart Vessels 30:692–695CrossRefPubMedGoogle Scholar
  21. 21.
    Suzuki J, Aoyama N, Aoki M, Tada Y, Wakayama K, Akazawa H, Shigematsu K, Hoshina K, Izumi Y, Komuro I, Miyata T, Hirata Y, Isobe M (2015) Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison between abdominal aortic aneurysm and arrhythmia. Heart Vessels 30:498–502CrossRefPubMedGoogle Scholar
  22. 22.
    Maeda H, Fujimoto C, Haruki Y, Maeda T, Kokeguchi S, Petelin M, Arai H, Tanimoto I, Nishimura F, Takashiba S (2003) Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria. FEMS Immunol Med Microbiol 39:81–86CrossRefPubMedGoogle Scholar
  23. 23.
    Ueno M, Izumi Y, Kawaguchi Y, Ikeda A, Iso H, Inoue M, Tsugane S, JPHC Study Group (2012) Prediagnostic plasma antibody levels to periodontopathic bacteria and risk of coronary heart disease. Int Heart J 53:209–214CrossRefPubMedGoogle Scholar
  24. 24.
    Soejima H, Oe Y, Nakayama H, Matsuo K, Fukunaga T, Sugamura K, Kawano H, Sugiyama S, Shinohara M, Izumi Y, Ogawa H (2009) Periodontal status and Prevotella intermedia antibody in acute coronary syndrome. Int J Cardiol 137:304–306CrossRefPubMedGoogle Scholar
  25. 25.
    Çalapkorur MU, Alkan BA, Tasdemir Z, Akcali Y, Saatçi E (2017) Association of peripheral arterial disease with periodontal disease: analysis of inflammatory cytokines and an acute phase protein in gingival crevicular fluid and serum. J Periodontal Res. doi: 10.1111/jre.12419 PubMedGoogle Scholar
  26. 26.
    Hujoel PP, DeRouen TA (1995) A survey of endpoint characteristics in periodontal clinical trials published 1988–1992, and implications for future studies. J Clin Periodontol 22:397–407CrossRefPubMedGoogle Scholar
  27. 27.
    Suzuki J, Shimamura M, Suda H, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Isobe M, Komuro I, Morishita R (2016) Current therapies and investigational drugs for peripheral arterial disease. Hypertens Res 39:183–191CrossRefPubMedGoogle Scholar
  28. 28.
    De Haro J, Acin F, Medina FJ, Lopez-Quintana A, March JR (2008) Relationship between the plasma concentration of C-reactive protein and severity of peripheral arterial disease. Clin Med Cardiol 3:1–7PubMedPubMedCentralGoogle Scholar
  29. 29.
    Ridker PM, Stampfer MJ, Rifai N (2001) Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a) and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285:2481–2485CrossRefPubMedGoogle Scholar
  30. 30.
    Bansal T, Pandey A, Asthana AK (2014) Creactive protein (CRP) and its association with periodontal disease: a brief review. J Clin Diagn Res 8:ZE21–ZE24PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Japan 2017

Authors and Affiliations

  • Norio Aoyama
    • 1
  • Jun-ichi Suzuki
    • 2
    • 3
  • Naho Kobayashi
    • 1
  • Tomoya Hanatani
    • 4
  • Norihiko Ashigaki
    • 5
  • Asuka Yoshida
    • 1
  • Yuka Shiheido
    • 1
  • Hiroki Sato
    • 1
  • Hidetoshi Kumagai
    • 2
  • Yuichi Ikeda
    • 6
  • Hiroshi Akazawa
    • 6
  • Issei Komuro
    • 6
  • Yuichi Izumi
    • 1
  • Mitsuaki Isobe
    • 3
  1. 1.Department of Periodontology, Graduate School of Medical and Dental SciencesTokyo Medical and Dental UniversityTokyoJapan
  2. 2.Department of Advanced Clinical Science and TherapeuticsUniversity of TokyoTokyoJapan
  3. 3.Department of Cardiovascular MedicineTokyo Medical and Dental UniversityTokyoJapan
  4. 4.Educational Cooperation CenterKyushu Dental UniversityKitakyushuJapan
  5. 5.Department of Oral MicrobiologyTsurumi UniversityYokohamaJapan
  6. 6.Department of Cardiovascular MedicineUniversity of TokyoTokyoJapan

Personalised recommendations